Kiromic Biopharma, Inc. (61) | Business Operations (7)

Browse by Subcategory

Recent Contracts

Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on February 16, 2022)
Form of Director Services Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors (Filed With SEC on June 26, 2020)
Voting Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc., certain investors and certain stockholders (Filed With SEC on May 11, 2020)
Collaboration Agreement, dated February 4, 2019, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc (Filed With SEC on May 11, 2020)
Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on February 2, 2022)
Form of Director Indemnification Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors (Filed With SEC on June 26, 2020)
Collaboration Agreement, dated February 6, 2020, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc (Filed With SEC on May 11, 2020)